Schiff base forming drugs: Mechanisms of immune potentiation and therapeutic potential

Journal of Molecular Medicine

Volumn 74, Issue 9, 1996, Pages 497-504

  Chen, H ^a   Rhodes, J ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Cell signalling; Costimulation; Immunopotentiation; Immunotherapy; Schiff base

Indexed keywords

B7 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CD86 ANTIGEN; CYTOKINE; IMMUNOSTIMULATING AGENT; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; SCHIFF BASE; T LYMPHOCYTE RECEPTOR; TUCARESOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTING CELL; CLINICAL TRIAL; CYTOTOXIC T LYMPHOCYTE; DRUG BIOAVAILABILITY; DRUG MECHANISM; HELPER CELL; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOMODULATION; IMMUNOPOTENTIATION; IMMUNOTOXICITY; MAJOR HISTOCOMPATIBILITY COMPLEX; MELANOMA; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; REVIEW; SUBCUTANEOUS DRUG ADMINISTRATION; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

EID: 0029817013     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00204975     Document Type: Review

References (61)

1. Hedrick SM, Eidelman FJ (1993) T lymphocyte antigen receptors. In: Paul W (ed) Fundamental immunology, 3rd edn. Raven, New York, pp 383-420
2. Weiss A (1993) T lymphocyte activation. In: Paul W (ed) Fundamental immunology, 3rd edn. Raven, New York, pp 467-504
3. Lenschow DJ, Bluestone JA (1993) T cell costimulation and in vivo tolerance. Curr Opin Immunol 5:747-752
4. Whittington R, Faulds D (1993) Interleukin-2. A review of its pharmacological properties and therapeutic use in patients with cancer. Drugs 46:446-514
5. Klima N, Pataraca R, Walling J et al (1994) Clinical and immunological changes in AIDS patients following adoptive therapy with activated autologous CD8 T cells and interelukin-2 infusion. AIDS 8:1073-1081
6. Hendrzak JA, Brunda MJ (1995) Interleukin-12. Biologic activity, therapeutic utility, and role in disease. Lab Invest 72:619-637
7. Tahara H, Lotze MT (1995) Anti-tumor effects of interleukin 12 (IL-12): applications for the immunotherapy and gene therapy of cancer. Gene Ther 2:96-106
8. Nabel GJ, Chang AE, Nabel EG et al (1994) Immunotherapy for cancer by direct gene transfer into tumors. Hum Gene Ther 5:57-77
9. Fenton RT, Sznol M, Luster DG, Taub DD, Longo DL (1994) A phase I trial of B7-transfected or parental lethally irradiated allogeneic melanoma cell lines to induce cell-mediated immunity against tumor associated antigen presented by HLA-A2 or HLA-A1 in patients with stage IV melanoma. NCI protocol T93-0161. BRMP protocol 9401. Hum Gene Ther 5:1385-1399
10. Rhodes J (1989) Evidence for an intercellular covalent reaction essential in antigen specific T-cell activation. J Immunol 143:1482-1489
11. Gao X-M, Rhodes J (1990) An essential role for constitutive Schiff base-forming ligands in antigen presentation to murine T cell clones. J Immunol 144:2883-2890
12. Rhodes J (1990) E-Rosettes provide an analogue for Schiff base formation in specific T cell activation. J Immunol 145:463-469
13. Rhodes J, Zheng B, Lifely MR (1992) Inhibition of specific T cell activation by monosaccharides is through their reactivity as aldehydes. Immunology 75:629-631
14. Zheng B, Brett S, Tite JP, Lifely MR, Brodie TA, Rhodes J (1992) Galactose oxidation in the design of immunogenic vaccines. Science 256:1560-1563
15. Rhodes J, Chen H, Hall SR, Beesley JE, Jenkins DC, Collins P. Zheng B (1995) Therapeutic potentiation of the immune system by costimulatory Schiff base forming drugs. Nature 377:71-75
16. Thompson CB (1995) Distinct roles for the costimulatory ligands B7-1 and B7-2 in T helper cell differentiation? Cell 81:979-82
17. Bluestone JA (1995) New perspectives on CD28-B7-mediated T cell costimulation. Immunity 2:555-559
18. Allison JP (1994) CD28-B7 interactions in T-cell activation. Curr Opin Immunol 6:414-419
19. Bell GM, Imboden JB (1995) CD2 and the regulation of T cell anergy. J Immunol 155:2805-2807
20. Shevach EM (1993) Accessory molecules. In: Paul W (ed) Fundamental immunology, 3rd edn. Raven, New York, pp 531-575
21. August A, Dupont B (1994) CD28 of T lymphocytes associates with phosphatidylinositol 3-kinase. Int Immunol 6:769-777
22. August AS, Gibson S, Kawakami Y, Kawakami T, Mills GB, Dupont B (1994) CD28 is associated with and induces the immediate tyrosine phosphorylation and activation of the Tec family kinase ITK/EMT in the human Jurkat leukemic T-cell line. Proc Natl Acad Sci USA 91:9347-9350
23. + T-cells. Science 271:1272-1276
24. + T-cells. Science 271:1276-1278
25. + T-cells. Annu Rev Immunol 12:635-673
26. Del-Prete G, Maggi E, Romagnani S (1994) Human Th1 and Th2 cells: functional properties, mechanisms of regulation, and role in disease. Lab Invest 70:299-306
27. Howard M, Miyajima A, Coffman R (1993) T-cell-derived cytokines and their receptors. In: Paul W (ed) Fundamental immunology, 3rd edn. Raven, New York, pp 763-800
28. Thompson CB (1995) Distinct roles for the costimulatory ligands B7-1 and B7-2 in T helper cell differentiation? Cell 81:979-983
29. Snell EE, Dimari SJ (1970) Schiff base intermediates in enzyme catalysis. In: Boyer PD (ed) The enzymes: kinetics and mechanism, vol 2. Academic, London, pp 335-346
30. Novogrodsky A, Katchalski E (1973) Induction of lymphocyte transformation by sequential treatment with neuraminidase and galactose oxidase. Proc Nat Acad Sci USA 70:1824-1827
31. John RA (1995) Pyridoxal phosphate-dependent enzymes. Biochim Biophys Acta 1248:81-96
32. Fherst A (1984) Covalent catalysis. In: Enzyme structure and mechanism, 2nd edn. Freeman, New York, pp 69-97
33. Van der Meer RA, Duine JA (1986) Covalently bound pyrroloquinoline quinone is the organic prosthetic group of human placental lysyl oxidase. Biochem J 239:789-791
34. Stryer L (1988) Excitable membranes and sensory systems. In: Biochemistry, 3rd edn. Freeman, New York, pp 1005-1041
35. Mukohata Y (1994) Comparative studies on ion pumps of the bacterial rhodopsin family. Biophys Chem 50:191-201
36. Sasaki J, Brown LS, Chon Y-S, et al. (1995) Conversion of bacteriorhodopsin into a chloride ion pump. Science 269:73-75
37. Chen H, Rogers M, Rhodes J (1996) Convergence of Schiff base costimulatory signaling and T-cell receptor signaling at the level of MAP kinase ERK2 (manuscript in preparation)
38. Seger R, Krebs EG (1995) The MAPK signaling cascade. FASEB J 9:726-735
39. Dudley DT, Pang L, Decker SJ , Bridges AJ, Saltiel AR (1995) A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc Natl Acad Sci USA 92:7686-7689
40. Greenlaw R, Robinson P, Heutun T, et al (1992) Transfection of HLA-DR-expressing DAP.3 cells with a cDNA clone encoding the glycosyl phosphatidylinositol-linked form of lymphocyte function associated antigen-3: biochemical features and functional consequences. Int Immunol 4:673-80
41. + T-cells is dependent on B7 (CD80) , augmented by CD58, but realtively unifluenced by CD54 expression. Im Immunol 7:1501-1513
42. Wyss DF, Choi JS, Maria JL et al (1995) Conformation and function of the N-linked glycan in the adhesion domain of human CD2. Science 269:1273-1278
43. Malkovsky M, Doré C, Hunt R et al (1983) Enhancement of specific antitumour immunity in mice fed a diet enriched in vitamin A acetate. Proc Natl Acad Sci 80:6322-6326
44. Malkovsky M, Edwards AJ, Hunt R et al (1983) T-cell mediated enhancement of host-versus-graft reactivity in mice fed a diet enriched with vitamin A acetate. Nature 302:338-340
45. Malkovsky M, Medawar PB, Thatcher DR et al (1985) Acquired immunological tolerance of foreign cells is impaired by recombinant interleukin 2 or vitamin A acetate. Proc Natl Acad Sci USA 82:536-538
46. Buck J, Derguini F, Levi R et al (1991) Intracellular signalling by 14-hydroxy-4,14-retro-retinol. Science 254:1645-1656
47. Derguini F, Nakanishi K, Hämmerling U et al (1994) Intracellular signalling activity of synthetic (14R)-, (14S)-, and (14RS)-14-hydroxy-4, 14-retro-retinol. Biochemistry 33: 623-628
48. 6 deficiency impairs interleukin 2 production and lymphocyte proliferation in elerly adults. Am J Clin Nutr 53:1275-1280
49. 6 and immune competence. Nutr Rev 51:217-225
50. Deeg HJ (1988) Ultraviolet irradiation in transplant biology: manipulation of immunity and immunogenicity. Transplantation 45:845-851
51. Ullrich SE (1995) Modulation of immunity by ultraviolet radiation: key effects on antigen presentation. J Invest Dermatol 105 [1 Suppl]:30S-36S
52. Kripke ML (1994) Ultraviolet radiation and immunology: something new under the sun - presidential address. Cancer Res 54:6102-6105
53. Tzianabos AO, Onderdonk AB, Rosner B et al (1993) Structural features of polysaccharides that induce intra-abdominal abscesses. Science 262:416-419
54. Tzianobos AO, Onderdonk AB, Smith RS et al (1994) Structure-function relationships for polysaccharide-induced intra-abdominal abscesses. Infect Immun 62:3590-3593
55. Edmonds SE, Ellis G, Gaffney K et al (1995) Hypoxia and the rheumatoid joint: immunological and therapeutic implications. Scand J Rheumatol Suppl 101: 163-168
56. Sherman DI, Williams R (1994) Liver damage: mechanisms and management. Br Med Bull 50:124-138
57. Love RA, Rader JI, Crofford LJ et al (1993) Pathological and immunological effects of ingesting L-tryptophan and 1,1′-ethylidenebis (L-tryptophan) in Lewis rats. J Clin Invest 91:804-811
58. Driskell WJ, Ashley DL, Grainger J et al (1992) Identification of decomposition products of 1,1′-ethylidenebis [L-tryptophan], a compound associated with eosinophilia-myalgia syndrome. Bull Environ Contam Toxicol 48:679-687
59. Pol S (1995) Immunotherapy of chronic hepatitis B by anti HBV vaccine. Biomed Pharmacother 49:105-109
60. Redfield RR, Birx DL (1992) HIV-specific vaccine therapy: concepts, status, and future directions. AIDS Res Hum Retro-viruses 8:1051-1058
61. Barth A, Hoon DS, Foshag LJ et al (1994) polyvalent melanoma cell vaccine induces delayed-type hypersensitivity and in vitro cellular immune response. Cancer Res 54:3342-3345